Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
SiMPore Inc., West Henrietta, New York.
Biotechnol Bioeng. 2020 Mar;117(3):879-885. doi: 10.1002/bit.27240. Epub 2019 Dec 18.
The widely used 0.2/0.22 µm polymer sterile filters were developed for small molecule and protein sterile filtration but are not well-suited for the production of large nonprotein biological therapeutics, resulting in significant yield loss and production cost increases. Here, we report on the development of membranes with isoporous sub-0.2 μm rectangular prism pores using silicon micromachining to produce microslit silicon nitride (MSN) membranes. The very high porosity (~33%) and ultrathin (200 nm) nature of the 0.2 µm MSN membranes results in a dramatically different structure than the traditional 0.2/0.22 µm polymer sterile filter, which yielded comparable performance properties (including gas and hydraulic permeance, maximum differential pressure tolerance, nanoparticle sieving/fouling behavior). The results from bacteria retention tests, conducted according to the guidance of regulatory agencies, demonstrated that the 0.2 µm MSN membranes can be effectively used as sterile filters. It is anticipated that the results and technologies presented in this study will find future utility in the production of non-protein biological therapeutics and in other biological and biomedical applications.
广泛使用的 0.2/0.22 μm 聚合物无菌过滤器是为小分子和蛋白质的无菌过滤而开发的,但不适合生产大型非蛋白质生物治疗药物,这会导致产量显著损失和生产成本增加。在这里,我们报告了使用硅微加工开发具有等孔亚 0.2 μm 矩形棱柱孔的膜的情况,以生产微狭缝氮化硅(MSN)膜。0.2 μm MSN 膜的非常高的孔隙率(约 33%)和超薄(200 nm)性质导致其结构与传统的 0.2/0.22 μm 聚合物无菌过滤器有很大不同,而后者的性能(包括气体和液压渗透性、最大压差耐受能力、纳米颗粒筛分/堵塞行为)相当。根据监管机构的指导进行的细菌保留测试的结果表明,0.2 μm MSN 膜可有效用作无菌过滤器。预计本研究中呈现的结果和技术将在非蛋白质生物治疗药物的生产以及其他生物和生物医学应用中找到未来的用途。